Shinji Asada

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

PloS one

International journal of nephrology and renovascular disease

Clinical and experimental nephrology

BMC nephrology

Kyowa Kirin Co. ltd.

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kyowa Kirin Co. ltd. Apr 01 2001

Japan

Manager :: Medical Affiars

Publications

Nobutaka Hattori, Daijiro Kabata, Shinji Asada, Tomoyuki Kanda, Takanobu Nomura, Ayumi Shintani, Akihisa Mori
Real-world evidence on levodopa dose escalation in patients with Parkinson's disease treated with istradefylline. PloS one 18 (12) (2023)
Nobutaka Hattori, Daijiro Kabata, Shinji Asada, Tomoyuki Kanda, Takanobu Nomura, Ayumi Shintani, Akihisa Mori
Real-world evidence on levodopa dose escalation in patients with Parkinson's disease treated with istradefylline. PloS one 18 (12) (2023)
Nobutaka Hattori, Daijiro Kabata, Shinji Asada, Tomoyuki Kanda, Takanobu Nomura, Ayumi Shintani, Akihisa Mori
Real-world evidence on levodopa dose escalation in patients with Parkinson's disease treated with istradefylline. PloS one 18 (12) (2023)
Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa
Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PloS one 17 (12) (2022)
Takashi Shigematsu, Shinji Asada, Yuichi Endo, Takehisa Kawata, Masafumi Fukagawa, Tadao Akizawa
Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism. PloS one 17 (2) (2022)
Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa
Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PloS one 17 (12) (2022)
Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa
Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PloS one 17 (12) (2022)
Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa
Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PloS one 17 (12) (2022)
Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa
Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PloS one 17 (12) (2022)
Takashi Shigematsu, Shinji Asada, Yuichi Endo, Takehisa Kawata, Masafumi Fukagawa, Tadao Akizawa
Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis. International journal of nephrology and renovascular disease 13 (2020)
Shinji Asada, Keitaro Yokoyama, Chisato Miyakoshi, Shingo Fukuma, Yuichi Endo, Michihito Wada, Takanobu Nomura, Yoshihiro Onishi, Masafumi Fukagawa, Shunichi Fukuhara, Tadao Akizawa
Relationship between serum calcium or phosphate levels and mortality stratified by parathyroid hormone level: an analysis from the MBD-5D study. Clinical and experimental nephrology 24 (7) (2020)
Chihiro Kato, Naohiko Fujii, Chisato Miyakoshi, Shinji Asada, Yoshihiro Onishi, Shingo Fukuma, Takanobu Nomura, Michihito Wada, Masafumi Fukagawa, Shunichi Fukuhara, Tadao Akizawa
Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism. BMC nephrology 21 (1) (2020)
Shinji Asada, Kazuki Yoshida, Shingo Fukuma, Takanobu Nomura, Michihito Wada, Yoshihiro Onishi, Noriaki Kurita, Masafumi Fukagawa, Shunichi Fukuhara, Tadao Akizawa
Effectiveness of cinacalcet treatment for secondary hyperparathyroidism on hospitalization: Results from the MBD-5D study. PloS one 14 (5) (2019)

Shinji Asada.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shinji Asada